MP33: Penile and Testicular Cancer I

Poster Session Moderator(s)

• jH

  jeff Holzbeierlein, MD

  Physician in Chief
  University of Kansas Health System
• 

  Curtis Pettaway, MD

  University of Texas M.D. Anderson Cancer Center
• 

  Phillip Pierorazio, MD (he/him/his)

  Professor
  University of Pennsylvania

Presentations:

• 9:30 AM – 11:30 AM CST

  MP33-01: Risk of residual teratoma after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumor and IGCCCG intermediate/poor prognosis: a multi-institutional retrospective cohort study
  

  Poster Presenter: Luca Antonelli, MD (he/him/his)
• 9:30 AM – 11:30 AM CST

  MP33-02: Primary Retroperitoneal Lymph Node Dissection for Metastatic Nonseminomatous Germ Cell Tumor: Review of Oncologic Outcomes and the Role of Adjuvant Chemotherapy
  

  Poster Presenter: Ahmad Mousa, MD
• 9:30 AM – 11:30 AM CST

  MP33-03: Comparative Cost-effectiveness of Treatment Strategies for Stage IIA Seminoma: Insights from the SEMS Trial
  

  Poster Presenter: Daniel Joyce, MD
• 9:30 AM – 11:30 AM CST

  MP33-04: The early results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) introduction of primary retroperitoneal lymph node dissection (RPLND) in seminoma stage IIA-IIb ≤ 3cm.
  

  Poster Presenter: Anna Thor, MD, PhD (she/her/hers) – Karolinska University Hospital
• 9:30 AM – 11:30 AM CST

  MP33-05: Neoadjuvant Platinum-Based Chemotherapy for Clinically Node-Positive Penile Squamous Cell Carcinoma: An International, Multicenter, Real-World Study
  

  Poster Presenter: Kyle M. Rose, MD, MS
• 9:30 AM – 11:30 AM CST

  MP33-06: Experience of the virtual Canadian testicular cancer second opinion group
  

  Poster Presenter: Jose De Jesus Cendejas Gomez, MD (he/him/his)
• 9:30 AM – 11:30 AM CST

  MP33-07: Anti-programmed death receptor 1 plus anti-epidermal growth factor receptor antibodies and combination chemotherapy for relapsed locally advanced and/or metastatic penile squamous cell carcinoma
  

  Poster Presenter: Longbin Xiong
• 9:30 AM – 11:30 AM CST

  MP33-08: Penile cancer care in the Netherlands over three decades: increased incidence, centralisation of care, and overall survival
  

  Poster Presenter: Manon Theodora Anna Vreeburg (she/her/hers)
• 9:30 AM – 11:30 AM CST

  MP33-09: Glansectomy and Neoglans reconstruction using Split-thickness Skin Graft / Acellular Dermal Matrix for Penile Cancer
  

  Poster Presenter: Haijun Yao, MD
• 9:30 AM – 11:30 AM CST

  MP33-10: Increased Genitourinary Cancer Incidence and Lower Testosterone Levels are Found in Men Performing Non-Standard Shift Work
  

  Poster Presenter: Larry I. Lipshultz, MD – Baylor College of Medicine
• 9:30 AM – 11:30 AM CST

  MP33-11: P16 status is an independent predictor of overall survival in metastatic penile cancer in a large contemporary cohort
  

  Poster Presenter: James A. Churchill, FRACS (he/him/his)
• 9:30 AM – 11:30 AM CST

  MP33-12: Comparing perioperative outcomes after robot assisted video endoscopic inguinal lymphadenectomy (RAVEIL) with open inguinal lymph node dissection (O-ILND) using propensity score match analysis
  

  Poster Presenter: Sheshang Kamath
• 9:30 AM – 11:30 AM CST

  MP33-13: Anticoagulation Prophylaxis Patterns following Retroperitoneal Lymph Node Dissection: A Ten-Year Retrospective Analysis
  

  Poster Presenter: Vincent D. D'andrea, MD (he/him/his)
• 9:30 AM – 11:30 AM CST

  MP33-14: Evaluation of miRNA-371a-3p (miR371a) assay to predict final pathohistology in patients undergoing primary nerve-sparing retroperitoneal lymphadenectomy (nsRPLND) for stage IIA/B seminomas and non-seminomas
  

  Poster Presenter: Axel Heidenreich, MD
• 9:30 AM – 11:30 AM CST

  MP33-15: Comparison of serum miR-371a-3p assay performance by digital droplet PCR and reverse transcriptase quantitative PCR in malignant germ cell tumor patients
  

  Poster Presenter: Aditya Bagrodia, MD – UC San Diego Health
• 9:30 AM – 11:30 AM CST

  MP33-16: Radiomics Model to predict teratoma in metastatic non-seminomatous testicular germ cell tumors
  

  Poster Presenter: Anna Scavuzzo
• 9:30 AM – 11:30 AM CST

  MP33-17: Examining Survival Outcomes by Race and Ethnicity in Testis Cancer: A Reverse Hispanic Paradox?
  

  Poster Presenter: Michael Rezaee
• 9:30 AM – 11:30 AM CST

  MP33-18: Surgical and Oncologic Outcomes of Surgery in Early Metastatic Seminoma: Multi-Institutional Retrospective Study
  

  Poster Presenter: Seyedeh Sanam Ladi Seyedian, MD
• 9:30 AM – 11:30 AM CST

  MP33-19: Molecular characteristics and actionable targets of testicular germ cell tumors in real-world conditions
  

  Poster Presenter: Aditya Bagrodia, MD – UC San Diego Health